What is Symprotek?
Symprotek Corporation is a specialized provider of turnkey PCB assembly and advanced manufacturing solutions. The company distinguishes itself through its adherence to stringent regulatory standards, holding ITAR and FDA registrations, alongside ISO 13485 certification, which is critical for medical device manufacturing. Symprotek offers tailored global supply chain solutions, particularly for small to mid-tier customers, with a strategic focus on achieving cost reductions as production volumes scale. Their comprehensive service portfolio also includes end-of-life product management, quick turn PCB assembly, and design engineering, positioning them as a versatile partner in the electronics manufacturing ecosystem.
How much funding has Symprotek raised?
Symprotek has raised a total of $740K across 2 funding rounds:
Debt
$350K
Debt
$390K
Debt (2020): $350K with participation from PPP
Debt (2021): $390K led by PPP
Key Investors in Symprotek
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor has participated in the recent strategic investment round, suggesting a potential interest in Symprotek's advanced manufacturing capabilities and market positioning.
What's next for Symprotek?
The substantial enterprise-level funding and recent strategic investment signal Symprotek's intent to further solidify its market presence and expand its manufacturing capabilities. With a clear focus on cost optimization and catering to the specific needs of small to mid-tier clients, the company is well-positioned to capitalize on increasing demand for specialized electronics manufacturing. Future growth is likely to be driven by leveraging its regulatory compliance and advanced manufacturing expertise, particularly within the medical device sector. Continued investment in supply chain solutions and product lifecycle management will be key to sustaining its competitive edge and achieving long-term strategic objectives.
See full Symprotek company page
